ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2187

Outcomes Following Tonsillectomy in Children with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome

Kalpana Manthiram1, Ana Ortega-Villa2, Sivia Lapidus3, Mary Bowes2, Tina Romeo4, Kathryn Garguilo5, Laura Failla2, Hemalatha Srinivasalu6, Pamela Mudd7, Roberta DeBiasi8, Amanda Ombrello9, Karyl Barron10, Daniel Kastner11 and Kathryn Edwards5, 1National Institute of Allergy and Infectious Disease, Bethesda, MD, 2National Institute of Allergy and Infectious Diseases, Bethesda, MD, 3Hackensack University Medical Center, Montclair, NJ, 4NIH, Bethesda, MD, 5Vanderbilt University School of Medicine, Nashville, TN, 6Children's National Hospital, Washington, DC, 7Children's National Hospital, Washington, 8Children's National Hospital and Research Institute, Washington, DC, 9National Institutes of Health, Rockville, MD, 10NIAID, NIH, Bethesda, MD, 11National Human Genome Research Institute, Bethesda, MD

Meeting: ACR Convergence 2024

Keywords: Autoinflammatory diseases, Pediatric rheumatology, Periodic Disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is the most common periodic fever syndrome in children. Tonsillectomy leads to cessation of febrile episodes in most children, but some continue to have symptoms after surgery. We evaluated a cohort of children with PFAPA who underwent tonsillectomy.

Methods: We characterized clinical features and response to tonsillectomy in 93 children with PFAPA from two different centers, Vanderbilt University Medical Center and the National Institutes of Health (NIH) in the United States, with subject/parent interviews and medical record review. We used multivariable logistic regression to identify predictors of favorable response to tonsillectomy.

Results: The 93 children enrolled in our study were followed for a median of 47 months after tonsillectomy. Overall, 48% had complete resolution of PFAPA episodes (65% at Vanderbilt, 34% at NIH), 25% had less severe or frequent episodes, 22% had a period of remission with recurrence, and 5% had no change in episodes. Children whose episodes aborted with corticosteroid or who had pharyngitis during flares prior to tonsillectomy were more likely to have a favorable response to surgery. Among those with continued flares after tonsillectomy, 63% (29/46) reported that some or all flares were feverless, and 44% (21/48) reported triggers for flares including physical and mental stress. Sixty-nine percent (33/48) of children with continued flares after tonsillectomy required treatment. Corticosteroid and anakinra were fully or partially effective in aborting flares in 86% and 100% of subjects who received these respective treatments post-tonsillectomy. Flare severity and frequency improved in 15/19 (79%) subjects who took cimetidine and 5/14 (36%) who took colchicine as prophylaxis. Most (67/93, 74%) children continued to have aphthous ulcers after tonsillectomy.

Conclusion: Tonsillectomy reduces episode severity and frequency in children with PFAPA. However, a portion of children with PFAPA, particularly those who do not respond to corticosteroids or who do not have pharyngitis during flares, have incomplete responses to tonsillectomy, potentially representing a subgroup of PFAPA with differences in disease mechanism.  

 This research was supported in part by the Division of Intramural Research of NIAID and NHGRI, NIH and T32 training grants at Vanderbilt University.


Disclosures: K. Manthiram: None; A. Ortega-Villa: None; S. Lapidus: None; M. Bowes: None; T. Romeo: None; K. Garguilo: None; L. Failla: None; H. Srinivasalu: None; P. Mudd: None; R. DeBiasi: None; A. Ombrello: None; K. Barron: None; D. Kastner: None; K. Edwards: Bionet, 2, Brighton Collaboration, 1, Dynavax, 2, IBM, 2, Merck, 1, Moderna, 1, Novavax, 1, Pfizer, 1, Roche, 1, Sanofi, 1, Seqirus, 1, X-4 Pharma, 1.

To cite this abstract in AMA style:

Manthiram K, Ortega-Villa A, Lapidus S, Bowes M, Romeo T, Garguilo K, Failla L, Srinivasalu H, Mudd P, DeBiasi R, Ombrello A, Barron K, Kastner D, Edwards K. Outcomes Following Tonsillectomy in Children with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/outcomes-following-tonsillectomy-in-children-with-periodic-fever-aphthous-stomatitis-pharyngitis-and-cervical-adenitis-pfapa-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/outcomes-following-tonsillectomy-in-children-with-periodic-fever-aphthous-stomatitis-pharyngitis-and-cervical-adenitis-pfapa-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology